These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7808024)

  • 1. The arotinoids: early clinical experience and discussion of future development.
    Arnold A; Kowaleski B; Tozer R; Hirte H
    Leukemia; 1994; 8 Suppl 3():S42-9. PubMed ID: 7808024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The arotinoids: early clinical experience and discussion of future development.
    Arnold A; Kowaleski B; Tozer R; Hirte H
    Leukemia; 1994 Nov; 8(11):1817-24. PubMed ID: 7967728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
    Flanagan JL; Willhite CC; Ferm VH
    J Natl Cancer Inst; 1987 Mar; 78(3):533-8. PubMed ID: 3469465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the therapeutic effects of a new arotinoid, Ro 40-8757, and all-trans- and 13-cis-retinoic acids on rat breast cancer.
    Teelmann K; Tsukaguchi T; Klaus M; Eliason JF
    Cancer Res; 1993 May; 53(10 Suppl):2319-25. PubMed ID: 8485719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoids. A review of their clinical pharmacology and therapeutic use.
    Orfanos CE; Ehlert R; Gollnick H
    Drugs; 1987 Oct; 34(4):459-503. PubMed ID: 3315625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials with retinoids for breast cancer chemoprevention.
    Zanardi S; Serrano D; Argusti A; Barile M; Puntoni M; Decensi A
    Endocr Relat Cancer; 2006 Mar; 13(1):51-68. PubMed ID: 16601279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoids and keratinocyte differentiation in vitro.
    Stadler R; Müller R; Detmar M; Orfanos CE
    Dermatologica; 1987; 175 Suppl 1():45-55. PubMed ID: 2446936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenretinide and its relation to cancer.
    Ulukaya E; Wood EJ
    Cancer Treat Rev; 1999 Aug; 25(4):229-35. PubMed ID: 10448131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoids and ovarian cancer.
    Zhang D; Holmes WF; Wu S; Soprano DR; Soprano KJ
    J Cell Physiol; 2000 Oct; 185(1):1-20. PubMed ID: 10942515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of topical retinoids in the treatment of acne.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Katsambas AD
    Clin Dermatol; 2004; 22(5):408-11. PubMed ID: 15556727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice.
    Stosić-Grujicić S; Cvjetićanin T; Stojanović I
    Mol Immunol; 2009 Nov; 47(1):79-86. PubMed ID: 19211146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-alpha.
    Louvet C; Djelloul S; Forgue-Lafitte ME; Mester J; Zimber A; Gespach C
    Br J Cancer; 1996 Aug; 74(3):394-9. PubMed ID: 8695354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cutaneous T-cell lymphoma with retinoids.
    Zhang C; Duvic M
    Dermatol Ther; 2006; 19(5):264-71. PubMed ID: 17014481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid tumours--chemoprevention with retinoids.
    Man T
    Leukemia; 1994 Oct; 8(10):1785-90. PubMed ID: 7934176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining retinoids with heteroatoms.
    Benbrook DM
    Mini Rev Med Chem; 2002 Jun; 2(3):277-83. PubMed ID: 12370069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil function in psoriasis: effects of retinoids.
    Coble BI; Dahlgren C; Molin L; Stendahl O
    Acta Derm Venereol; 1987; 67(6):481-90. PubMed ID: 2451372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-tumor arotinoid Ro 40-8757 protects bone marrow from the toxic effects of 5-fluorouracil.
    Eliason JF; Inoue T; Kubota A; Horii I; Hartmann D
    Int J Cancer; 1994 Apr; 57(2):192-7. PubMed ID: 8157357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-tumor arotinoid Ro 40-8757 protects bone marrow from the toxic effects of cyclophosphamide.
    Eliason JF; Inoue T; Kubota A; Teelmann K; Horii I; Hartmann D
    Int J Cancer; 1993 Sep; 55(3):492-7. PubMed ID: 8375933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-proliferative effects of the arotinoid Ro 40-8757 on human cancer cell lines in vitro.
    Eliason JF; Kaufmann F; Tanaka T; Tsukaguchi T
    Br J Cancer; 1993 Jun; 67(6):1293-8. PubMed ID: 8390284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.